We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

    The Antibody Mediated Prevention trials showed that the broadly neutralizing antibody (bnAb) VRC01 prevented acquisition of human immunodeficiency...

    Peter B. Gilbert, Yunda Huang, ... Lynn Morris in Nature Medicine
    Article Open access 22 August 2022
  2. Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

    Background

    Both SARS-CoV-2 mRNA-based vaccines [BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna)] have shown high efficacy, with very modest side...

    Maria Antonietta Isgrò, Giusy Trillò, ... Rocco Saviano in Infectious Agents and Cancer
    Article Open access 28 July 2022
  3. Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium

    During biotherapeutic drug development, immunogenicity is evaluated by measuring anti-drug antibodies (ADAs). The presence and magnitude of ADA...

    Marta Starcevic Manning, Mohamed Hassanein, ... Viswanath Devanarayan in The AAPS Journal
    Article Open access 12 July 2022
  4. Production of Neutralizing Antibody

    Techniques employing monoclonal antibodies (mAbs) are widely used in the initial development phase of biologics. The usefulness of mAbs in basic RA...
    Erika Takemasa, Shuang Liu in Rheumatoid Arthritis
    Protocol 2024
  5. Anti-drug Antibody Magnitude and Clinical Relevance Using Signal to Noise (S/N): Bococizumab Case Study

    Historically, the biopharmaceutical industry has used titer to characterize the magnitude of an anti-drug antibody (ADA) response. While reporting...

    Fred McCush, Ellen Wang, ... Daniel Baltrukonis in The AAPS Journal
    Article 02 September 2023
  6. Viral Titer Quantification of West Nile Virus by Immunostaining Plaque Assay

    Immunostained plaque assay based on the specific antibody binding to viral antigen enables the detection and titration of virus infectivity,...
    Na Li, Cheng-Lin Deng, ... Han-Qing Ye in West Nile Virus
    Protocol 2023
  7. The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case–control study

    Background

    Coronavirus disease 2019 (COVID-19) causes life-threatening pneumonia. Convalescent plasma therapy (CPT) is expected to be the effective...

    Nuttakant Nontawong, Taweegrit Siripongboonsitti, ... Nithi Mahanonda in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 19 November 2022
  8. Exercise 9: Determination of Antibody Titer and Screening Techniques

    The amount of antibody present in an antiserum can be determined by a variety of serologic reactions that are based on the detection of...
    Chapter 2021
  9. Production of Secreted Antibody in Baculovirus Expression Vector System

    Monoclonal antibodies have widespread applications in disease treatment and antigen detection. They are traditionally produced using mammalian cell...
    Zhihui Zhang, **aoyue Zhang, ... Hongying Chen in Baculovirus
    Protocol 2024
  10. Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

    Background

    The phase I trial of the humanized anti-CD26 monoclonal antibody YS110 for CD26-expressing tumors was conducted recently. The present study...

    Yutaro Kaneko, Ryo Hatano, ... Chikao Morimoto in Biomarker Research
    Article Open access 23 March 2021
  11. Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model

    Mouse models are useful for the early down-selection of malaria vaccine candidates. The Walter Reed Army Institute of Research has optimized a...

    Christopher J. Genito, Katherine Brooks, ... Sheetij Dutta in npj Vaccines
    Article Open access 10 August 2023
  12. Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus

    Hantaan virus (HTNV) is a pathogenic orthohantavirus prevalent in East Asia that is known to cause hemorrhagic fever with severe renal syndrome...

    Hui Zhang, He Liu, ... Fanglin Zhang in npj Vaccines
    Article Open access 10 February 2024
  13. Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older

    Background

    Seasonal influenza causes significant morbidity and mortality with a disproportionately high disease burden in older adults....

    Bettina Wunderlich, Thomas Laskow, ... Sean X. Leng in Immunity & Ageing
    Article Open access 31 July 2023
  14. Despite low viral titer in saliva samples, Sanger-based SARS-CoV-2 spike gene sequencing is highly applicable for the variant identification

    Background

    This study aimed to compare the performance of Sanger-based SARS-CoV-2 spike gene sequencing and Next Generation Sequencing (NGS)-based...

    Ko Ko, Kazuaki Takahashi, ... Junko Tanaka in BMC Medical Genomics
    Article Open access 24 August 2023
  15. An Antibody-Dependent Cellular Cytotoxicity Assay for Detecting Ocrelizumab Neutralizing Antibody

    Ocrelizumab (OCREVUS®) is a humanized anti-CD20 monoclonal antibody approved for the treatment of adult patients with relapsing multiple sclerosis...

    Van Nguyen, Anthony Cheung, ... Shan Chung in The AAPS Journal
    Article 02 October 2023
  16. The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

    Current seasonal and pre-pandemic influenza vaccines induce short-lived predominantly strain-specific and limited heterosubtypic responses. To better...

    Johannes B. Goll, Aarti Jain, ... Philip L. Felgner in npj Vaccines
    Article Open access 30 August 2022
  17. ADAMTS13 Antibody and Inhibitor Assays

    A finding of an ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif, member 13) activity level of <10% of normal is...
    Gary W. Moore, Helga Vetr, Nikolaus B. Binder in Hemostasis and Thrombosis
    Protocol 2023
  18. Evolution of Antidrug Antibody Assays During the Development of Anti-Tissue Factor Pathway Inhibitor Monoclonal Antibody Marstacimab

    Tissue factor pathway inhibitor (TFPI) is an endogenous inhibitor of the extrinsic coagulation pathway. In patients with hemophilia A or B,...

    Jean Donley, Darshana Jani, ... Steven Arkin in The AAPS Journal
    Article Open access 23 August 2023
  19. Characteristics and Outcomes of Anti-interferon Gamma Antibody-Associated Adult Onset Immunodeficiency

    Purpose

    Anti-interferon gamma antibody (AIGA) is a rare cause of adult onset immunodeficiency, leading to severe disseminated opportunistic infections...

    Bingqing Zhang, Junpin Fan, ... Xuejun Zeng in Journal of Clinical Immunology
    Article Open access 26 June 2023
  20. Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic

    Purpose

    The purpose of this study is to investigate the kinetics of response against SARS-CoV-2 elicited by vaccination and/or breakthrough infection...

    Giulia Anna Maria Luigia Costanzo, Carla Maria Deiana, ... Davide Firinu in Journal of Clinical Immunology
    Article 22 December 2023
Did you find what you were looking for? Share feedback.